Sangamo Therapeutics
SGMO
#10548
Rank
NZ$52.1 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-82.97%
Change (1 year)

P/S ratio for Sangamo Therapeutics (SGMO)

P/S ratio as of August 2026 (TTM): 0.8872

According to Sangamo Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.62. At the end of 2026 the company had a P/S ratio of 3.45.

P/S ratio history for Sangamo Therapeutics from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.45-7.5%
20253.73-59.62%
20249.241590.23%
20230.5467-88.17%
20224.62-53.15%
20219.87-47.15%
202018.797.06%
20199.48-31.78%
201813.9-63.36%
201737.9241.21%
201611.1-31.62%
201516.2-29.06%
201422.9-36.08%
201335.8143.29%
201214.71.97%
201114.4-0.28%
201014.520.63%
200912.036.26%
20088.81-84.73%
200757.796.7%
200629.3-40.88%
200549.6-56.97%
2004115117.86%
200352.9208.67%
200217.1-63.37%
200146.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.50 632.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.01 577.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
3.03 241.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
0.5741-35.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5.66 538.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.89 451.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
6.90 678.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
4.15 368.05%๐Ÿ‡บ๐Ÿ‡ธ USA